BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17437735)

  • 21. Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.
    Stevens VL; Rodriguez C; Pavluck AL; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1226-8. PubMed ID: 16775186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study.
    Gluba A; Banach M; Rysz J; Piotrowski G; Fendler W; Pietrucha T
    Angiology; 2009; 60(5):588-95. PubMed ID: 19505886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions and associations of paraoxonase gene cluster polymorphisms with myocardial infarction in a Pakistani population.
    Saeed M; Perwaiz Iqbal M; Yousuf FA; Perveen S; Shafiq M; Sajid J; Frossard PM
    Clin Genet; 2007 Mar; 71(3):238-44. PubMed ID: 17309646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renin-angiotensin system and nitric oxide synthase gene polymorphisms in relation to stroke.
    Henskens LH; Kroon AA; van der Schouw YT; Schiffers PM; Grobbee DE; de Leeuw PW; Bots ML
    Am J Hypertens; 2007 Jul; 20(7):764-70. PubMed ID: 17586411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men.
    Zhang C; Lopez-Ridaura R; Hunter DJ; Rifai N; Hu FB
    Diabetes; 2006 Jul; 55(7):2140-7. PubMed ID: 16804086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
    Clarimon J; Eerola J; Hellström O; Tienari PJ; Singleton A
    Neurosci Lett; 2004 Sep; 367(2):168-70. PubMed ID: 15331145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
    Stevens VL; Rodriguez C; Talbot JT; Pavluck AL; Thun MJ; Calle EE
    Prostate; 2008 Sep; 68(12):1336-40. PubMed ID: 18500687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
    Kovács TJ; Harris S; Vas TK; Seres I; Short CD; Wittmann IK; Paragh G; Mackness MI; Mackness B; Durrington PN; Nagy JM; Brenchley PE
    J Nephrol; 2006; 19(6):732-8. PubMed ID: 17173245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a case-control study in a Chinese population.
    Cheng J; Liu J; Li X; Yu L; Peng J; Zhang R; Geng Y; Nie S
    Clin Chim Acta; 2008 Jun; 392(1-2):46-51. PubMed ID: 18396156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association between a common polymorphism near the INSIG2 gene and BMI, myocardial infarction, and cardiovascular risk factors.
    Wiedmann S; Neureuther K; Stark K; Reinhard W; Kallmünzer B; Baessler A; Fischer M; Linsel-Nitschke P; Erdmann J; Schunkert H; Hengstenberg C
    Obesity (Silver Spring); 2009 Jul; 17(7):1390-5. PubMed ID: 19197259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A myocardial infarction genetic risk score is associated with markers of carotid atherosclerosis.
    Hamrefors V; Hedblad B; Engström G; Almgren P; Sjögren M; Melander O
    J Intern Med; 2012 Mar; 271(3):271-81. PubMed ID: 22017383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial nitric oxide synthase gene (T-786C) polymorphism in patients with slow coronary flow.
    Nurkalem Z; Tangurek B; Zencirci E; Alper AT; Aksu H; Erer B; Gorgulu S; Ciloglu F; Eren M
    Coron Artery Dis; 2008 Mar; 19(2):85-8. PubMed ID: 18300744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.
    Koch W; Hoppmann P; de Waha A; Schömig A; Kastrati A
    Hum Mol Genet; 2008 Apr; 17(8):1120-6. PubMed ID: 18178577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.
    Kallel A; Sbaï MH; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
    Cytokine; 2013 Dec; 64(3):646-51. PubMed ID: 24095258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    J Diabetes Complications; 2008; 22(5):331-8. PubMed ID: 18413207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases.
    Rechciński T; Grebowska A; Kurpesa M; Peruga Z; Dziuba M; Krzemińska-Pakuła M; Rudnicka W; Chmiela M
    Kardiol Pol; 2007 Mar; 65(3):237-44; discussion 245. PubMed ID: 17436151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The features of myocardial infarction clinical course at gene of endothelial NO-synthase polymorphisms].
    Popova LV; Nikolaev KIu; Nikolaeva AA; Voronina EN
    Klin Med (Mosk); 2008; 86(4):32-5. PubMed ID: 18494283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of polymorphisms in the beta2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension.
    Misono M; Maeda S; Iemitsu M; Nakata Y; Otsuki T; Sugawara J; Zempo H; Yoshizawa M; Miyaki A; Kuno S; Matsuda M; Ajisaka R
    J Hypertens; 2009 Jul; 27(7):1377-83. PubMed ID: 19373110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.